News | Health & Safety
18 Feb 2018 8:39
NZCity News
NZCity CalculatorReturn to NZCity

  • Start Page
  • Personalise
  • Sport
  • Weather
  • Finance
  • Shopping
  • Jobs
  • Horoscopes
  • Lotto Results
  • Photo Gallery
  • Site Gallery
  • TVNow
  • Dating
  • SearchNZ
  • NZSearch
  • Crime.co.nz
  • RugbyLeague
  • Make Home
  • About NZCity
  • Contact NZCity
  • Your Privacy
  • Advertising
  • Login
  • Join for Free

  •   Home > News > Health & Safety

    Pacific Edge shares up 3.8pc on US deal

    Pacific Edge's shares jumped despite selling on the local index, after the cancer diagnostics company announced a deal with a US insurance provider network.


    Pacific Edge's shares jumped despite broad-based selling on the local index, after the cancer diagnostics company announced a deal with a US insurance provider network.

    In a statement to the NZX, Pacific Edge said its agreement with MediNcrease Health Plans will make its Cxbladder tests available to 5.5 million covered lives through its clients and payers.

    Cxbladder is a suite of non-invasive laboratory tests for the detection and management of bladder cancer.

    The shares rose 3.8 per cent to 41 cents, while the S/NZX All Index was down 1.3 per cent to 1463.58 at the time.

    The local bourse has come under pressure on Wednesday, following global sharemarkets lower after selling began in US markets over the weekend, though it escaped heavy selling Tuesday as it was closed for Waitangi Day.

    Pacific Edge's chief executive David Darling said commercial agreements with provider networks were important for the company's presence in the US, as it minimises barriers for urologists who order Cxbladder tests for their patient care.

    "This agreement will make Cxbladder tests accessible through MediNcrease's client base of regional and national health plans, insurance companies, employers, municipalities, third-party administrators, unions and other companies involved in the management of medical claims and will help facilitate expedited payments to Pacific Edge," the company said.

    It did not disclose the value of the deal.

    Last year, the Dunedin-based company reported a first-half net loss of $8.7 million, compared to a loss of $11.3m a year earlier.

    The company raised $21.3m in October in a deeply discounted rights issue, which it said would fund its goal to break even in the 2019 financial year.


    NZN




    © 2018 NZN, NZCity


     Other Health & Safety News
     17 Feb: Disease killing starfish may spread to NZ
     15 Feb: Dr Bawa-Garba: Who's to blame when a medical tragedy occurs?
     15 Feb: Survey shows youth smoking at all-time low
     14 Feb: Call for third vaccine dose against mumps
     13 Feb: NZ shares rise as all eyes on Fletcher
     12 Feb: Third measles case in Canterbury
     12 Feb: Optometrist fails boy with brain tumour
     Top Stories

    RUGBY RUGBY
    Blues lose young flanker to injury More...


    BUSINESS BUSINESS
    NZ shares up, Tourism Holdings hits record More...



     Today's News

    Law and Order:
    Donald Trump's Guantanamo Bay 8:15

    Rugby League:
    Sharks win NRL trial win against Manly 7:55

    Politics:
    Cyclists head to Auckland Harbour Bridge 7:45

    Living & Travel:
    One dead after Canterbury crash 7:35

    Accident and Emergency:
    Ammonia leak at Tegel in Taranaki 7:25

    Rugby League:
    Broncos thrash Titans 38-10 in NRL trial 7:15

    Soccer:
    10-man Reds snatch draw with Mariners 7:05

    Cricket:
    Aussies buoyant ahead of Eden Park return 6:25

    Living & Travel:
    Chinese New Year: Remembering how I first ate dog meat, and how differences bring us together 4:35

    Rugby League:
    Dufty shines, Dragons rusty against Hull 23:05


     News Search






    Power Search


    © 2018 New Zealand City Ltd